DE69626916D1 - Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten - Google Patents

Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten

Info

Publication number
DE69626916D1
DE69626916D1 DE69626916T DE69626916T DE69626916D1 DE 69626916 D1 DE69626916 D1 DE 69626916D1 DE 69626916 T DE69626916 T DE 69626916T DE 69626916 T DE69626916 T DE 69626916T DE 69626916 D1 DE69626916 D1 DE 69626916D1
Authority
DE
Germany
Prior art keywords
myocardial infarction
sertraline
infarction patients
treat post
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69626916T
Other languages
English (en)
Other versions
DE69626916T2 (de
Inventor
Brian F Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69626916D1 publication Critical patent/DE69626916D1/de
Application granted granted Critical
Publication of DE69626916T2 publication Critical patent/DE69626916T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69626916T 1995-07-17 1996-07-03 Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten Expired - Fee Related DE69626916T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US143795P 1995-07-17 1995-07-17

Publications (2)

Publication Number Publication Date
DE69626916D1 true DE69626916D1 (de) 2003-04-30
DE69626916T2 DE69626916T2 (de) 2003-10-09

Family

ID=21696010

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69626916T Expired - Fee Related DE69626916T2 (de) 1995-07-17 1996-07-03 Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten

Country Status (15)

Country Link
EP (1) EP0768083B1 (de)
JP (1) JPH0930959A (de)
KR (1) KR970005283A (de)
CN (1) CN1147937A (de)
AT (1) ATE235237T1 (de)
AU (1) AU721967B2 (de)
CA (1) CA2181225C (de)
DE (1) DE69626916T2 (de)
DK (1) DK0768083T3 (de)
ES (1) ES2192217T3 (de)
IL (1) IL118833A (de)
MY (1) MY117638A (de)
NZ (1) NZ299006A (de)
PT (1) PT768083E (de)
ZA (1) ZA966027B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU724635B2 (en) * 1997-07-01 2000-09-28 Pfizer Products Inc. Gelatine encapsulated solution dosage forms of sertraline
EP0999830A1 (de) 1997-07-01 2000-05-17 Pfizer Inc. Sertraline salze und dozierungsformen für dauerverabreichung enthaltend sertraline
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
CA2346335C (en) * 1998-10-13 2006-04-18 Pfizer Products Inc. Sertraline oral concentrate
US6727283B2 (en) * 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
US6245782B1 (en) 1999-05-17 2001-06-12 Heartdrug Research L.L.C. Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
GB0814466D0 (en) * 2008-08-07 2008-09-10 Rosemont Pharmaceuticals Ltd Sertraline composition
JP2022532637A (ja) * 2019-05-15 2022-07-15 バステラ カンパニー リミテッド オートファジー活性化剤を有効成分として含む心脳血管疾患の予防または治療用組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114976A (en) * 1989-01-06 1992-05-19 Norden Michael J Method for treating certain psychiatric disorders and certain psychiatric symptoms

Also Published As

Publication number Publication date
MY117638A (en) 2004-07-31
EP0768083B1 (de) 2003-03-26
PT768083E (pt) 2003-08-29
JPH0930959A (ja) 1997-02-04
AU721967B2 (en) 2000-07-20
IL118833A0 (en) 1996-10-31
CN1147937A (zh) 1997-04-23
DK0768083T3 (da) 2003-06-23
ZA966027B (en) 1998-01-16
EP0768083A2 (de) 1997-04-16
ES2192217T3 (es) 2003-10-01
CA2181225C (en) 1999-03-23
NZ299006A (en) 2000-08-25
AU6053496A (en) 1997-01-23
CA2181225A1 (en) 1997-01-18
IL118833A (en) 2000-07-26
ATE235237T1 (de) 2003-04-15
DE69626916T2 (de) 2003-10-09
EP0768083A3 (de) 1999-12-01
KR970005283A (ko) 1997-02-19

Similar Documents

Publication Publication Date Title
ATE110958T1 (de) Verwendung von sertralin zur behandlung verfrühter ejakulation.
DE69434431D1 (de) Methoden zur behandlung von muskelerkrankungen und muskelstörungen
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
DE60216830D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
DE69626916T2 (de) Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69621786T2 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
ATE96999T1 (de) Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen.
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
MX9602793A (es) Uso de sertralina para tratar pacientes despues de un infarto de miocardio.
SE9501773D0 (sv) New use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee